lobbying_activities: 1106703

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1106703	23f806f6-1779-4fd2-a454-baef7910a4c3	Q2	LAW OFFICES OF MARC SHAPIRO	400761290	POZEN INC.	2011	second_quarter	MED	Amendment of new drug approval provisions of Federal Food, Drug and Cosmetic Act; no bill pending	HOUSE OF REPRESENTATIVES	20000		0	0	2011-06-27T14:39:20.957000-04:00